Cleared Traditional

PHILIPS INTEGRIS ALLURA FLAT DETECTOR RELEASE 1.2 (K031333) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K031333 · Philips Medical Systems North America, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2003
Decision
15d
Days
Class 2
Risk

K031333 is an FDA 510(k) clearance for the PHILIPS INTEGRIS ALLURA FLAT DETECTOR RELEASE 1.2. Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Philips Medical Systems North America, Inc. (Da Best, NL). The FDA issued a Cleared decision on May 13, 2003 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Philips Medical Systems North America, Inc. devices

Submission Details

510(k) Number K031333 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 28, 2003
Decision Date May 13, 2003
Days to Decision 15 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 107d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 46
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K031333.
INTEGRATED INNOVA - S5I SYSTEM OPTION
K111209 · Ge Healthcare · Jul 2011
ARTIS ZEE / ZEEGOS WITH SW VC14
K090745 · Siemens Medical Solutions USA, Inc. · Jun 2009
ARTIS ZEE AND ZEEGO
K073290 · Siemens Medical Solutions USA, Inc. · Feb 2008
DIGITAL IMAGING SYSTEM (BSR)
K991922 · Siemens Medical Solutions USA, Inc. · Sep 1999
ADVANTX LCN, ADVANTX LCLP
K974367 · GE Medical Systems · Feb 1998
ADVANTX LCV+
K960575 · GE Medical Systems · May 1996